Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Biochim Biophys Acta. 2010 Feb 1;1801(5):559–566. doi: 10.1016/j.bbalip.2010.01.007

Fig. 8. Effects of HIV-protease inhibitor treatment on proteins involved in fatty acid transport and metabolism in C2C12 myotubes.

Fig. 8

Representative immunoblots for FABPpm, FATP1, and FATP4 (A), CD36 (B), CPT1 (C), and SREBP-1 (D) in whole cell lysates of C2C12 myotubes following treatment for 18 h with vehicle (DMSO) alone (Con) or with PI’s in combination (ATV/r, LPV/r, and DRV/r; 20/5 μmol/l, respectively). Tubulin (A) or GAPDH (B-D) were used as loading controls. E. Quantitation of immunoreactive CD36, CPT1, and SREBP-1 bands. The target immunoreactive bands were normalized to GAPDH loading control and the data are presented as fold-change relative to untreated Con sample. (*Significantly different from corresponding Con group, p < 0.0001, n =3).